Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • "Use of Test Significantly Impacts Treatment Recommendations for One in Four Men and Improves Confidence in 85 Percent of Physicians"

    Prostate reimbursement progress should be a huge catalyst for this stock this year....and once reimbursement similar to Breast coverage is achieved, liquid biopsy will be that much closer to market. Pipeline.

  • You might also like to note that the two "YTD +21%" posts I mentioned below are also proof that the individual you've been defending has been bragging for the last ten years about profits from trades he never made.

    My posting history includes a post last August listing the history of that imaginary trade - which starts with two posts explaining why he'd decided not to make it :-)

    Only a "trader" who has never shorted a stock in his life would claim (as he did recently) to be "benefiting from both sides of the trade" by simultaneously holding Long and Short positions.

    A trader with a Long position who anticipates a drop in the share price wouldn't borrow shares in order to sell short before he'd first sold the shares he already owned.

    A trader with a Short position who anticipates a rise in the share price wouldn't buy shares and just hold on to them. Any rise in the value of those shares would only benefit the lender of the shares used to establish the Short position. And until those shares are returned they'd be accruing fees.

    People who lie about their achievements are compensating for something missing in their lives.

  • Supporting Wider Adoption and Reimbursement = Co PR this am

  • The ignore is a beautiful thing - arikaycerocks terryamln( not my id) petenphil cvarg44 believe2200

  • I have. In the posting history for the AMLN alias he uses here you'll find this post from February 21 2013 -

    "eye giggle on ignore as the clowns get embarrassed....these clowns like to follow me around ...
    YTD +21% short since $7.81"

    The thread containing that post opens with a post under his main INSM alias boasting -

    "short since $7.81 YTD 21%".

    He's a modern day village idiot who can't keep his hands off his metaphysical weenie.

    A search for the word "blush" on the INSM board (change "3 months" to "All") unearths the use of "I blush" by the main INSM alias he currently uses - and the main (all boards) alias he was using back in 2002 - and a third alias he used on May 16 2006 (when replying to his docmomamln alias).

    A search for "wine cellar" unearths, also posted under that third "blushing" alias -

    "Im also *****m87/amln*****.. ), also a 50 center(actually my 19k@0.38) hasnt allowed me your wine cellar,but I remain happily retires in San Diego."

    A search for "the ignore is a beautiful thing" - an expression he used two weeks ago on this board - removes all reasonable doubt.

    And yes - the posting history for the AMLN alias he uses here frequently mentions his hot flushes ...

    March 7 2012 -

    "hit my orders while I played in the surf and sand! - ) ... I blush, and here's my truck ..."

    Words such as "optomistic", "scenerio", "expediated" and "stratagy" betray his use of well over a hundred aliases -

    "The stratagy works because it is after the fear,the shorts and the ride on the biotech rollercoaster.(NDA,FDA etc)
    Analysts ability to "move" a stock will be overtaken by what will be the marketplace in 2 years.(look at post 70's bear market for historical perspective) A marketplace of valuations and earnings.
    GNTA IMHO will have them....soooooooooo But it tuck it away dont'LOOK !come back in 2 years
    Good Luck to all Longs"

    Sadly his GNTA ride only took him to GNTAQ.

    When luck figures in a biotech investment strategy there is usually only one outcome.

  • You'd better have a stronger link to that forgery and the spamming of the INSM board than two people using the name Terry.

  • Reply to

    Just deny you're involvement Terry

    by petenphil Apr 27, 2015 12:18 PM

    Now there's a surprise. He refuses to answer either question.

    If you were in his position - responsible for the spamming of this board by people who mistakenly believed you'd been spamming the INSM board - wouldn't you as a common courtesy to your fellow GHDX shareholders state categorically that you were blameless?

    And what possible reason could he have had for ignoring your April 16 request to elaborate upon his claimed 49.9999% Baker Brothers ownership?

    At least you have his posting history, which includes

    1. April 6 2015 -

    "OT Clown alert! arikrocks ( jad9000 etc) from the INSM bd - stupid - Bkers @ 49.9999 % ... This poster following me around appears to be a kid, but its been years that I have made a ton shorting INSM ( long now) and she has lost big time on Insmed. Again she has no knowledge of the subject. Bakers own 49.9999 % is a FACT - this clown is posting only the BB holdings Ltd. and does not include the Baker on the BOD or the Baker in charge of R&D ( insider holdings) with posts like this you can see why is a joke over on the Insmed board"

    2. May 16 2014 -

    "OK out 2500 x 0.51= $$$ Lunch money.I know I know these kids dont have a clue but from the looks of my whited out bd and thumbs- their Life is complete! ... the XXXX trade worked better Have more fun kids...Surfs up"

    3. June 27 2013 -

    "Warning = little girls at play ... I see you clowns are on the Genomic board as well. There is a reason you clowns have lost so much investing,first of all, your kids. ignore on High"

    4. June 7 2013 -

    "Cathy says you are truly amazing ! There is no doubt you are a foolish biotech investor as well as a total neurotic."

    5. March 5 2012 -

    "hit my orders while I played in the surf and sand! - )"

    Therefore you DO know -

    1. he was an INSM investor.

    2. he hates the INSM Longs with a vengeance.

    3. he doesn't understand Beneficial Ownership disclosure.

    4. he doesn't understand punctuation.

    5. he doesn't understand that grown-ups don't "play" on beaches.

  • Reply to

    Back to the 20s again

    by terryamln Apr 27, 2015 3:53 PM

    Looks like my girls have been by to visit...I tried to tell ya!! For every action there is an equal and opposite reaction. Stop drinking on the weekends and all will be fine.

    Good Luck

  • I just want my 35 buys back

  • Reply to

    deja vu all over again.

    by terry_vrng Apr 27, 2015 1:49 PM

    All over again...

  • Reply to

    I am OUT. 5 years holding and sold for a loss

    by terryamln Apr 25, 2015 2:17 PM

    I tried to tell you guys and gals...I blush with this call.....

  • Reply to

    Just deny you're involvement Terry

    by petenphil Apr 27, 2015 12:18 PM

    Yes it is terry....drinking all weekend and postING on the insm board due to anger over losses at vrng...

  • I loss so much on AMLN and VRNG and now this one is heading into the crapper. I just can't invest and trade very well.

  • Reply to

    I am OUT. 5 years holding and sold for a loss

    by terryamln Apr 25, 2015 2:17 PM

    It is a good thing...Tide is down now dude.

  • Shorting this and covering sure is cutting into my surfing time. MO MONEY to Surf...is what I always say.

  • Terry, the spammers seem convinced you've been disrupting the INSM board by using aliases mimicking INSM longs. For the record, have you ever used any of these aliases mentioned by Arikaycerocks?

    jad90000
    kvmncdd
    be_leaguered
    bohemainclubman
    Blasedp3l

    Also, can you confirm the Bakers own 49.9999% of Genomic please?

  • Hmm - further evidence of a severely-restricted ability to envisage the consequences of one's actions.

    By way of background - a year or two back Shire purchased from Insmed the rights for the use of the drug iPlex in the prevention of retinopathy in premature babies.

    1. Original - posted April 10 on the MNKD board -

    FDA: AstraZeneca's diabetes drug Onglyza may increase death rate

    April 10 (Reuters) - AstraZeneca Plc's diabetes drug Onglyza may be associated with an increased rate of death, according to a preliminary review of data by the U.S. Food and Drug Administration.

    The FDA's report, posted on the agency's website on Friday, comes ahead of an April 14 meeting of an FDA advisory panel to discuss the drug's safety.

    A company-sponsored trial of more than 16,000 patients known as SAVOR previously showed patients taking Onglyza, also known as saxagliptin, had an increased risk of hospitalizations due to heart failure.

    The agency's analysis found the heart failure risk valid. It also identified a possible increased risk of death from all causes.

    contd ...

    2. Forgery - posted today on the INSM board -

    FDA: Shires drug iplex may increase death rate

    (Reuters) -Shires drug for ROP may be associated with an increased rate of death, according to a preliminary review of data by the U.S. Food and Drug Administration.

    The FDA's report, posted on the agency's website on Friday,

    A company-sponsored trial of more than 2000 patients known as iplex showed patients taking iplex,, had an increased risk of hospitalizations due to heart failure.

    The agency's analysis found the heart failure risk valid. It also identified a possible increased risk of death from all causes.

    contd ...

    An INSM Long posts as b_leaguered. The forgery was posted under the alias be_leaguered.

  • Reply to

    I am OUT. 5 years holding and sold for a loss

    by terryamln Apr 25, 2015 2:17 PM

    Terence Dan Mooney, 1633 Diamond ST San Diego, CA 92109

GHDX
28.28+1.21(+4.47%)May 1 4:00 PMEDT